• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Nature reviews. Urology >The future of bladder cancer care in the USA
【24h】

The future of bladder cancer care in the USA

机译：美国膀胱癌护理的未来

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Bladder cancer is the fifth most common malignancy in the USA and the most expensive to treat on a per-patient basis. Despite its prevalence, morbidity, mortality and associated cost of management, bladder cancer remains grossly under-recognized as a public health concern and underfunded scientifically. Although 5-year survival rates for patients with prostate or kidney cancer have improved tremendously in the past 30 years, progress in bladder cancer has stalled. A renewed interest from the clinical and research communities, as well as a young and eager advocacy network, are raising the profile of bladder cancer. As awareness and funding of bladder cancer increase, improved diagnostics, therapeutics and health services for patients with the disease will develop accordingly.
机译：膀胱癌是美国第五大最常见的恶性肿瘤，每位患者治疗费用最高。尽管膀胱癌的患病率，发病率，死亡率和相关的管理成本，但仍然严重不足以将其视为公共卫生问题，并且科学上资金不足。尽管在过去30年中，前列腺癌或肾癌患者的5年生存率有了很大提高，但膀胱癌的进展却停滞了。来自临床和研究界的新兴趣以及一个年轻而热切的倡导网络正在提高膀胱癌的知名度。随着对膀胱癌的认识和资金的增加，将为患有该疾病的患者提供改进的诊断，治疗和健康服务。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号